SAT0376 Serum CRP Levels Demonstrate Predictive Value for Radiographic and MRI Outcomes in Patients with Active as Treated with The TNF-Inhibitor Golimumab

Abstract

BackgroundWhile the introduction of anti-tumor necrosis tumor (TNF) biologic agents can significantly improve signs/symptoms of ankylosing spondylitis (AS) and reduce magnetic resonance imaging (MRI)-detected spinal inflammation, the effect of such...